WeVote
Log In

Bill

Bill

HD 4484

An Act relative to Topical Steroid Withdrawal Syndrome

194th Legislature (2025-2026) Introduced by Barry Finegold and 2 co-sponsors

Establishes a Massachusetts commission to study topical steroid addiction/withdrawal, raise awareness, and guide prevention, early detection, treatment, and prescribing practices.

Reported, referred to the committee on Joint Rules, reported, rules suspended and referred to the committee on Public Health
0
WeVote Research Nonpartisan
Bill Summary · HD 4484

Summary of House Bill HD 4484: An Act relative to Topical Steroid Withdrawal Syndrome

Overview

HD 4484 proposes the creation of a special commission to research Topical Steroid Addiction and Topical Steroid Withdrawal Syndrome (TSWS), a condition described as severe and debilitating that can arise from exposure to topical steroids. The bill would add a new section (Section 245) to Chapter 111 of the General Laws to establish this commission and outline its duties, composition, and reporting requirements.

Purpose and Intent

  • Establish a formal body to study, understand, and raise awareness about topical steroid addiction and TSWS.
  • Inform medical protocols for prevention, early detection, and treatment.
  • Improve awareness among health care providers, patients, and consumers when prescribing topical steroids.

Key Provisions

  • Establishment of a special commission to research topical steroid addiction and TSWS.
  • Authority to conduct public hearings, forums, or meetings to gather information and to generate awareness.
  • The commission’s work is aimed at prevention, early detection, and treatment, as well as informing prescribing practices.

Commission Composition

  • 1 member representing a Commonwealth department (non-specified department).
  • 7 governor-appointed members, including:
    • 1 dermatologist
    • 1 licensed pediatrician
    • 1 licensed pharmacist
    • 1 licensed immunologist
    • 3 individuals or parents who have been impacted by TSWS
  • The governor’s appointees are in addition to the department representative.

Activities and Reporting

  • The commission may hold hearings, forums, and meetings to gather information and raise awareness among health care providers, patients, and consumers regarding topical steroids and TSWS.
  • Annual reporting requirement: On or before June 30 each year, the commission must provide a report to the governor and the clerks of the Massachusetts House and Senate, who will forward it to the Joint Committee on Public Health.
  • Annual report should include recommendations and drafts of legislation necessary to implement those recommendations.
  • The commission may file interim reports and recommendations as it deems appropriate.

Procedural and Timeline Aspects

  • Introduced: March 27, 2025.
  • Initial status: Reported, referred to the committee on Joint Rules; later actions indicate a path to Public Health after rules suspension.
  • Latest actions: 2025-10-27 — reported, referred to Joint Rules, reported, rules suspended and referred to Public Health (reflecting progression through committee processes).
  • No specific appropriation or funding is stated in the text provided.
  • The bill would amend Chapter 111 by adding Section 245 to create and govern the commission.

Who Would Be Affected

  • Individuals and families affected by TSWS (as potential appointees and stakeholders).
  • Health care professionals (dermatologists, pediatricians, pharmacists, immunologists) who may engage with the commission and implement findings.
  • Policymakers and public health officials who would receive commission reports and consider recommended legislation.

Potential Impact

  • Increased research and awareness of TSWS.
  • Development of standardized protocols for prevention, detection, and treatment.
  • Informing prescribing practices for topical steroids through evidence-based guidance.
  • Possible groundwork for future policy measures based on commission recommendations.

If you’d like, I can tailor this summary to emphasize practical implications for clinicians, patients, or policymakers, or add a quick comparison to related public health commissions.

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.